Non-interventional (observational) post-licensure study to assess the effectiveness and safety of recombinant zoster vaccine in adults aged =18 years with psoriasis or psoriatic arthritis (EPI-ZOSTER-045 VE US 216976)

20/10/2023
29/07/2026
EU PAS number:
EUPAS107230
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol Anonymized_216976

English (1.65 MB - PDF) View document
Study results
Study report
Abstract of study report

Abstract-Anonymised 28 Jul 2026.pdf

English (85 KB - PDF) View document
Study report

Clinical Study Report Epi-Zoster-045_NIS CSR Final-Anonymised 23 Jul 2026.pdf

English (4.01 MB - PDF) View document
Other information